Regional hemodynamic effects of antihypertensive renomedullary lipids in conscious rats

James E. Faber, Kirk W. Barron, Ann C. Bonham, Rodney Lappe, E. Eric Muirhead, Michael J. Brody

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Renomedullary tissue has been proposed to exert an antihypertensive endocrine-like action. The antihypertensive polar renomedullary lipids (APRL) and neutral renomedullary lipids (ANRL) are potential mediators of this action. We evaluated the blood pressure and regional hemodynamic responses to APRL administered peripherally (i.v.) and to the central nervous system (CNS) in normal rats and rats with sinoaortic deafferentation (SAD) to remove baroreflex buffering. Rats were chronically instrumented with Doppler flow probes for measurement of mesenteric, renal, and hindquarter vascular resistance, with arterial pressure and intravenous catheters, and with lateral cerebroventricular cannuli for intracerebroventricular (i.c.v.) administration. Intravenous APRL (0.01 to 1.0 μg) produced a dose-dependent decrease in blood pressure, tachycardia, and dilation of all vascular beds studied. The dose-response relationships were shifted to the left in SAD animals. APRL administered i.c.v. had no effect on intact or SAD rats. Pressor and regional vasoconstrictor responses to norepinephrine, angiotensin, and vasopressin were markedly reduced in SAD animals during constant infusion of APRL. In a second group of conscious SAD animals instrumented for blood pressure and heart rate measurements, intravenous ANRL (500pig) decreased both arterial pressure (−45 ± 16 mm Hg) and heart rate (−5 0 ± 16bpm). When given i.c.v., however, ANRL (10-100 μg) had no significant effect on resting blood pressure or heart rate. These studies suggest that APRL and ANRL produce no significant cardiovascular effects that are mediated through the CNS. However, both lipids are potent depressor agents, and APRL exhibits a strong peripheral vasodilator action and nonspecificallv reduces reactivity to vasoconstrictor agents.

Original languageEnglish
Pages (from-to)494-502
Number of pages9
JournalHypertension
Volume6
Issue number4
DOIs
StatePublished - 1 Jan 1984

Fingerprint

Antihypertensive Agents
Hemodynamics
Lipids
Blood Pressure
Heart Rate
Vasoconstrictor Agents
Arterial Pressure
Central Nervous System
1-hexadecyl-2-acetyl-glycero-3-phosphocholine
Baroreflex
Angiotensins
Vasopressins
Vasodilator Agents
Tachycardia
Vascular Resistance
Action Potentials
Blood Vessels
Dilatation
Norepinephrine
Catheters

Keywords

  • Angiotensin II
  • Blood pressure regulation
  • Central nervous system action
  • Norepinephrine
  • Sinoaortic deafferentation
  • Vascular resistance
  • Vasopressin

Cite this

Faber, James E. ; Barron, Kirk W. ; Bonham, Ann C. ; Lappe, Rodney ; Eric Muirhead, E. ; Brody, Michael J. / Regional hemodynamic effects of antihypertensive renomedullary lipids in conscious rats. In: Hypertension. 1984 ; Vol. 6, No. 4. pp. 494-502.
@article{e4cdfe1efcca4eccbe63c79c6a6d3e50,
title = "Regional hemodynamic effects of antihypertensive renomedullary lipids in conscious rats",
abstract = "Renomedullary tissue has been proposed to exert an antihypertensive endocrine-like action. The antihypertensive polar renomedullary lipids (APRL) and neutral renomedullary lipids (ANRL) are potential mediators of this action. We evaluated the blood pressure and regional hemodynamic responses to APRL administered peripherally (i.v.) and to the central nervous system (CNS) in normal rats and rats with sinoaortic deafferentation (SAD) to remove baroreflex buffering. Rats were chronically instrumented with Doppler flow probes for measurement of mesenteric, renal, and hindquarter vascular resistance, with arterial pressure and intravenous catheters, and with lateral cerebroventricular cannuli for intracerebroventricular (i.c.v.) administration. Intravenous APRL (0.01 to 1.0 μg) produced a dose-dependent decrease in blood pressure, tachycardia, and dilation of all vascular beds studied. The dose-response relationships were shifted to the left in SAD animals. APRL administered i.c.v. had no effect on intact or SAD rats. Pressor and regional vasoconstrictor responses to norepinephrine, angiotensin, and vasopressin were markedly reduced in SAD animals during constant infusion of APRL. In a second group of conscious SAD animals instrumented for blood pressure and heart rate measurements, intravenous ANRL (500pig) decreased both arterial pressure (−45 ± 16 mm Hg) and heart rate (−5 0 ± 16bpm). When given i.c.v., however, ANRL (10-100 μg) had no significant effect on resting blood pressure or heart rate. These studies suggest that APRL and ANRL produce no significant cardiovascular effects that are mediated through the CNS. However, both lipids are potent depressor agents, and APRL exhibits a strong peripheral vasodilator action and nonspecificallv reduces reactivity to vasoconstrictor agents.",
keywords = "Angiotensin II, Blood pressure regulation, Central nervous system action, Norepinephrine, Sinoaortic deafferentation, Vascular resistance, Vasopressin",
author = "Faber, {James E.} and Barron, {Kirk W.} and Bonham, {Ann C.} and Rodney Lappe and {Eric Muirhead}, E. and Brody, {Michael J.}",
year = "1984",
month = "1",
day = "1",
doi = "10.1161/01.HYP.6.4.494",
language = "English",
volume = "6",
pages = "494--502",
journal = "Hypertension",
issn = "0194-911X",
publisher = "Lippincott Williams and Wilkins Ltd.",
number = "4",

}

Faber, JE, Barron, KW, Bonham, AC, Lappe, R, Eric Muirhead, E & Brody, MJ 1984, 'Regional hemodynamic effects of antihypertensive renomedullary lipids in conscious rats', Hypertension, vol. 6, no. 4, pp. 494-502. https://doi.org/10.1161/01.HYP.6.4.494

Regional hemodynamic effects of antihypertensive renomedullary lipids in conscious rats. / Faber, James E.; Barron, Kirk W.; Bonham, Ann C.; Lappe, Rodney; Eric Muirhead, E.; Brody, Michael J.

In: Hypertension, Vol. 6, No. 4, 01.01.1984, p. 494-502.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Regional hemodynamic effects of antihypertensive renomedullary lipids in conscious rats

AU - Faber, James E.

AU - Barron, Kirk W.

AU - Bonham, Ann C.

AU - Lappe, Rodney

AU - Eric Muirhead, E.

AU - Brody, Michael J.

PY - 1984/1/1

Y1 - 1984/1/1

N2 - Renomedullary tissue has been proposed to exert an antihypertensive endocrine-like action. The antihypertensive polar renomedullary lipids (APRL) and neutral renomedullary lipids (ANRL) are potential mediators of this action. We evaluated the blood pressure and regional hemodynamic responses to APRL administered peripherally (i.v.) and to the central nervous system (CNS) in normal rats and rats with sinoaortic deafferentation (SAD) to remove baroreflex buffering. Rats were chronically instrumented with Doppler flow probes for measurement of mesenteric, renal, and hindquarter vascular resistance, with arterial pressure and intravenous catheters, and with lateral cerebroventricular cannuli for intracerebroventricular (i.c.v.) administration. Intravenous APRL (0.01 to 1.0 μg) produced a dose-dependent decrease in blood pressure, tachycardia, and dilation of all vascular beds studied. The dose-response relationships were shifted to the left in SAD animals. APRL administered i.c.v. had no effect on intact or SAD rats. Pressor and regional vasoconstrictor responses to norepinephrine, angiotensin, and vasopressin were markedly reduced in SAD animals during constant infusion of APRL. In a second group of conscious SAD animals instrumented for blood pressure and heart rate measurements, intravenous ANRL (500pig) decreased both arterial pressure (−45 ± 16 mm Hg) and heart rate (−5 0 ± 16bpm). When given i.c.v., however, ANRL (10-100 μg) had no significant effect on resting blood pressure or heart rate. These studies suggest that APRL and ANRL produce no significant cardiovascular effects that are mediated through the CNS. However, both lipids are potent depressor agents, and APRL exhibits a strong peripheral vasodilator action and nonspecificallv reduces reactivity to vasoconstrictor agents.

AB - Renomedullary tissue has been proposed to exert an antihypertensive endocrine-like action. The antihypertensive polar renomedullary lipids (APRL) and neutral renomedullary lipids (ANRL) are potential mediators of this action. We evaluated the blood pressure and regional hemodynamic responses to APRL administered peripherally (i.v.) and to the central nervous system (CNS) in normal rats and rats with sinoaortic deafferentation (SAD) to remove baroreflex buffering. Rats were chronically instrumented with Doppler flow probes for measurement of mesenteric, renal, and hindquarter vascular resistance, with arterial pressure and intravenous catheters, and with lateral cerebroventricular cannuli for intracerebroventricular (i.c.v.) administration. Intravenous APRL (0.01 to 1.0 μg) produced a dose-dependent decrease in blood pressure, tachycardia, and dilation of all vascular beds studied. The dose-response relationships were shifted to the left in SAD animals. APRL administered i.c.v. had no effect on intact or SAD rats. Pressor and regional vasoconstrictor responses to norepinephrine, angiotensin, and vasopressin were markedly reduced in SAD animals during constant infusion of APRL. In a second group of conscious SAD animals instrumented for blood pressure and heart rate measurements, intravenous ANRL (500pig) decreased both arterial pressure (−45 ± 16 mm Hg) and heart rate (−5 0 ± 16bpm). When given i.c.v., however, ANRL (10-100 μg) had no significant effect on resting blood pressure or heart rate. These studies suggest that APRL and ANRL produce no significant cardiovascular effects that are mediated through the CNS. However, both lipids are potent depressor agents, and APRL exhibits a strong peripheral vasodilator action and nonspecificallv reduces reactivity to vasoconstrictor agents.

KW - Angiotensin II

KW - Blood pressure regulation

KW - Central nervous system action

KW - Norepinephrine

KW - Sinoaortic deafferentation

KW - Vascular resistance

KW - Vasopressin

UR - http://www.scopus.com/inward/record.url?scp=0021137706&partnerID=8YFLogxK

U2 - 10.1161/01.HYP.6.4.494

DO - 10.1161/01.HYP.6.4.494

M3 - Article

C2 - 6746083

AN - SCOPUS:0021137706

VL - 6

SP - 494

EP - 502

JO - Hypertension

JF - Hypertension

SN - 0194-911X

IS - 4

ER -